[Thalidomide and cancer--revival of a drug].
Leibovici
D
D
Lindner
A
A
D020533:Angiogenesis Inhibitors / Q000633:toxicity; D000818:Animals; D000970:Antineoplastic Agents; D002470:Cell Survival / Q000187:drug effects; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D013723:Teratogens; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D014407:Tumor Cells, Cultured
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D013723:Teratogens; D013792:Thalidomide